Panjon
- Market cap
- ₹ 30 Cr.
- P/E
- 49.4x
- P/B
- 1.92x
- 52-week range
- 16.16 – 30
- ROE
- 4%
- ROCE
- 4.9%
- Dividend yield
- 0%
- Debt / equity
- 0.24
- Sector
- Food Products
- Industry
- Packaged Foods
- Listed on
- BSE
About
Panjon Limited is an India-based company engaged in the manufacturing and trading of consumer and pharmaceutical products. The Company specializes in medicinal, digestive, ayurvedic and confectionary products. Its products include PANJON Tablet, PANJON Balm, PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy, Percy Masala Candy, Panjon Swad PACHAK range: Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Packaged Foods: 56 companies →Panjon against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)49.4 against a typical 40.6: pricier than most peers (1st = cheapest).33rd of 56
- Sales growth+25.7% against a typical +15.3% from a year earlier.14th of 45
- Profit growth+22.2% against a typical +7.5% from a year earlier.14th of 40
- Share price, 3 months−4% against a typical −10.1%.17th of 51
- Size₹ 29.5 Cr. market value against a typical ₹ 99 Cr. (1st = largest).37th of 53
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 5 | 5 | 2 | 3 | 11 | 14 | 6 | 15 | 14 | 12 | 8 |
| Expenses | 1 | 5 | 5 | 2 | 3 | 11 | 14 | 6 | 15 | 14 | 12 | 8 |
| Operating Profit | 0 | 0 | −0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPM % | 2.3% | 0.2% | −0.6% | 1% | 2.1% | 2.1% | 2.2% | 3% | 1.7% | 2.1% | 2% | 2.4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 64.7% | 0% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.12 | 0.13 | 0.05 | 0.13 | 0.13 | 0.03 | 0.06 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 15%
- 5 Years
- 27%
- 3 Years
- 98%
- TTM
- 42%
- 10 Years
- 5%
- 5 Years
- 43%
- 3 Years
- −10%
- TTM
- 3%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 9%
- TTM
- —
- 10 Years
- −1%
- 5 Years
- −3%
- 3 Years
- 2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Panjon | ₹ 18.69 | ₹ 30 Cr. | 49.4x | 1.9x | 4% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 38.4x | 5.6x | 14.2% | 19.1% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 73.3x | 11.5x | 16.2% | 24.3% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 72.7x | 19.2x | 27.1% | 15.3% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 27.6x | 3.3x | 11.8% | 13.7% |
| Zydus Lifesciences | ₹ 1,127.85 | ₹ 1,12,503 Cr. | 21.2x | 4.2x | 19.7% | 18.5% |
Management
- Jay Kumar Kothari
- Executive Chairman of the Board, Managing Director
- Pramod Kumar Ajmera
- Chief Financial Officer
- Anju Jay Kothari
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.